
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.
Author: Charlotte Edmond, Senior Writer, Forum Agenda
- The medical diagnostics market is rapidly growing and becoming more high-tech.Sensors in contact lenses, shopping trolleys and restrooms are some of the more surprising places the technology is cropping up.A World Economic Forum report highlights how diagnostics will be key to ensuring equality of care and access to therapeutics.
The adage “prevention is better than a cure” is never truer than when applied to healthcare. And a growing diagnostics market is helping make that a reality. Healthcare systems around the world are increasingly adopting medical technologies that support intervention at an earlier stage. Diseases can be detected earlier, risk factors identified and addressed or mitigated, and treatments can be more targeted.The use of these technologies is not restricted to hospitals and healthcare settings – people are increasingly monitoring their own health. A good example of this is continuous glucose monitoring which is becoming more commonplace and allows diabetes patients to get on with their lives thanks to a device that tracks blood sugar levels. But a monitor on your arm might seem prosaic compared to some of the places diagnostic technologies are cropping up.
Researchers at Stanford University and POSTECH have developed a smart contact lens that can continuously monitor glucose levels. Using nanoparticles embedded in the polymer hydrogel that forms the lens, the device provides a non-invasive way to monitor for high or low sugar levels. It directly correlates glucose levels in tears and blood without needing another medical device like a glucometer.
Your bodily fluids can tell physicians a lot about your health. And its continuous monitoring can help detect changes and biomarkers that may indicate less than optimum health.In future, “smart” toilets could become a feature in your bathroom, collecting samples and feeding back data. They could help detect disease markers for illnesses such as colorectal or urological cancers. They could be helpful to those with a genetic predisposition to conditions like irritable bowel syndrome, prostate cancer or kidney failure.
How is the World Economic Forum bringing data-driven healthcare to life?
The application of “precision medicine” to save and improve lives relies on good-quality, easily-accessible data on everything from our DNA to lifestyle and environmental factors. The opposite to a one-size-fits-all healthcare system, it has vast, untapped potential to transform the treatment and prediction of rare diseases—and disease in general.But there is no global governance framework for such data and no common data portal. This is a problem that contributes to the premature deaths of hundreds of millions of rare-disease patients worldwide. The World Economic Forum’s Breaking Barriers to Health Data Governance initiative is focused on creating, testing and growing a framework to support effective and responsible access – across borders – to sensitive health data for the treatment and diagnosis of rare diseases. The data will be shared via a “federated data system”: a decentralized approach that allows different institutions to access each other’s data without that data ever leaving the organization it originated from. This is done via an application programming interface and strikes a balance between simply pooling data (posing security concerns) and limiting access completely. The project is a collaboration between entities in the UK (Genomics England), Australia (Australian Genomics Health Alliance), Canada (Genomics4RD), and the US (Intermountain Healthcare).
The growth in the smartwatch market has provided researchers with a wealth of information about our daily habits, heart rate and exercise routines. The data generated by wearable devices could also be used to detect Parkinson’s disease, researchers from Cardiff University believe. Parkinson’s is typified by motor changes that bring about tremors and slowness of movement, but non-motor changes can pre-date the onset of these symptoms by many years. Early diagnosis of the disease can be difficult.However, using Artificial Intelligence (AI) analysis of data gathered from the accelerometers in smartwatches, scientists could distinguish people living with Parkinson’s, including those in the early stages, from the general population.
Atrial fibrillation causes an abnormal heart rhythm and can increase the risk of stroke. But if the condition is picked up early, treatment options are available. A trial by researchers in the UK saw electrocardiogram sensors fitted in the handles of supermarket trolleys. Over 2,000 adults were scanned by holding the handle for at least 60 seconds, with some participants who were unaware they were affected subsequently contacted to arrange a follow-up appointment.
Trending now:
Discover more from The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com
Subscribe to get the latest posts sent to your email.







































Why don't you drop your comment here?